[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100501059":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":22,"responsibleParty":41,"collaborators":10,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":10,"enrollmentInfo":53,"targetDuration":56,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Western Sydney Local Health District","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patient with Gastrointestinal neoplasm",null,"Pt referred for resection of gastrointestinal neoplasm. Observational data collected from endoscopic submucosal dissection (ESD), submucosal-tunnelling endoscopic resection (STER) or endoscopic full-thickness resection (EFTR) of gastrointestinal neoplasm",[13],{"name":14,"affiliation":15,"role":16},"Michael Bourke","WSLHD","PRINCIPAL_INVESTIGATOR",[18],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","02 8890 5555","michael@citywestgastro.com.au",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Westmead Hospital","RECRUITING","Sydney","New South Wales","2145","Australia","AU",{"type":32,"coordinates":33},"Point",[34,35],151.20732,-33.86785,{"lat":35,"lon":34},[38],{"name":39,"role":19,"phone":10,"phoneExt":10,"email":40},"Clarence Kerrison","clarence.kerrison@health.nsw.gov.au",{"type":16,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Professor Michael Bourke","Director of Endoscopy","100501059","the-australia-and-new-zealand-multicentre-upper-gastrointestinal-endoscopic-tissue-resection-study-100501059",false,"NCT05804331","The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study","ANZ UGI","Inclusion Criteria:\n\n* UGI neoplastic lesions \\> 10mm\n\n  * Lesions for ESD limited to the mucosal and\u002For submucosal layer OR\n  * Lesions for EFTR limited to the muscularis propria layer OR\n  * Lesions for STER limited to the submucosal and\u002For muscularis propria layer\n* Aged 18 years or older\n\nExclusion Criteria:\n\n* Age less than 18\n* Unable to give informed consent\n* Pregnant or lactating patients\n* Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally","ALL","18 Years",{"count":54,"type":55},500,"ESTIMATED","3 Years","OBSERVATIONAL","To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions",[60,61,62,63,64,65,66,67,68],"Cancer of Stomach","Oesophageal Cancer","Gastric Cancer","Gastric Adenocarcinoma","GI Cancer","GIST","Neuroendocrine Tumors","Gastric Neoplasm","Esophageal Neoplasms","2025-03-25",{"date":71,"type":72},"2025-03-27","ACTUAL",{"date":74,"type":72},"2023-03-14",{"date":76,"type":55},"2028-09-14",{"name":5,"class":6},1]